Page last updated: 2024-08-21

alpha-aminopyridine and Nephrotic Syndrome

alpha-aminopyridine has been researched along with Nephrotic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kikuchi, D; Okada, K; Takahashi, M; Usui, K; Watanabe, Y1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Nephrotic Syndrome

ArticleYear
The risk of nephrotic syndrome with non-VEGF inhibitory antineoplastic drugs: from viewpoint of the adverse event reports in Japan.
    Clinical and experimental nephrology, 2021, Volume: 25, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Aminopyridines; Antineoplastic Agents; Dasatinib; Humans; Japan; Lactams; Nephrotic Syndrome; Odds Ratio; Pyrazoles; Risk Factors; Vascular Endothelial Growth Factor A

2021